ArticleCureus2026
The Effect of Two Different Intraoperative Doses of Dexmedetomidine on Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Major Abdominal Surgery Under General Anesthesia: A Randomized Controlled Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative cognitive dysfunction (POCD) is a significant complication among elderly patients undergoing major abdominal surgery. Dexmedetomidine is commonly used as an adjunct to general anaesthesia, but the effect of different intraoperative dosing regimens on early postoperative cognitive outcomes remains unclear. This study evaluated the impact of two different dexmedetomidine doses on early postoperative cognitive outcomes.
methodsA randomized, double-blind, controlled study was conducted on 72 elderly patients (≥60 years) undergoing elective major abdominal surgery under general anaesthesia. Patients were allocated into three groups (n = 24 each): Group P (placebo), Group D1 (dexmedetomidine 1 µg/kg bolus + 0.2 µg/kg/hr infusion), and Group D2 (dexmedetomidine 1.5 µg/kg bolus + 0.5 µg/kg/hr infusion). Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) scale preoperatively and at one, six, and 24 hours postoperatively. A decline of more than five points was considered significant POCD. Hemodynamic parameters and adverse events were also recorded.
resultsBaseline characteristics were comparable across all groups. At one hour postoperatively, MoCA scores were significantly higher in D1 and D2 compared with placebo (p = 0.046). At six hours, cognitive recovery was significantly better in D2, followed by D1, compared with placebo (p < 0.001). The incidence of significant cognitive decline (>5-point fall) was lowest in D1 and D2 (12.5% each) and highest in the placebo group (37.5%, p = 0.048). Dexmedetomidine groups showed more stable intraoperative hemodynamics without significant increases in adverse events.
conclusionIntraoperative dexmedetomidine significantly attenuates early POCD in elderly patients undergoing major abdominal surgery, with the higher dose demonstrating the greatest cognitive preservation. Dexmedetomidine may be safely incorporated into anaesthetic protocols to improve postoperative neurocognitive outcomes in high-risk elderly surgical patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.